Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A07EC02	PENTASA XTEND	B	Mesalazine - 2g	2g	Granules for suspension	8,550,789 L.L
A07EC02	ASACOL	B	Mesalazine - 500mg	500mg	Suppository	1,703,992 L.L
A07EC02	SALOFALK 500	B	Mesalazine - 500mg	500mg	Suppository	677,297 L.L
A07EC02	SALCROZINE	G	Mesalazine - 500mg	500mg	Suppository	576,508 L.L
A07EC02	SALCROZINE	G	Mesalazine - 1000mg	1000mg	Suppository	2,306,034 L.L
A07EC02	PENTASA	B	Mesalazine - 1g	1g	Suppository	4,153,817 L.L
A07EC02	SALOFALK	B	Mesalazine - 1g	1g	Suppository	3,948,209 L.L
A07EC02	SALOFALK	B	Mesalazine - 4g/60ml	4g/60ml	Enema	3,796,355 L.L
A07EC02	ASACOL	B	Mesalazine - 1g/100ml	1g/100ml	Enema	2,748,158 L.L
A07EC02	PENTASA	B	Mesalazine - 1g	1g	Enema	2,791,161 L.L
A07EC02	SALOFALK	B	Mesalazine - 1.5g	1.5g	Granules, gastro-resistant, prolonged release	6,150,767 L.L
A07EC02	SALOFALK	B	Mesalazine - 3g	3g	Granules, gastro-resistant, prolonged release	11,256,652 L.L
A07EC02	ASACOL	B	Mesalazine - 1600mg	1600mg	Tablet, modified release	8,454,523 L.L
A07EC02	ASACOL	B	Mesalazine - 1600mg	1600mg	Tablet, modified release	12,310,378 L.L
A07EC02	PENTASA	B	Mesalazine - 4g	4g	Granules, prolonged release	8,513,063 L.L
A07FA02	ULTRA LEVURE	B	Saccharomyces boulardii - 50mg	50mg	Capsule	381,651 L.L
A07FA02	ULTRA LEVURE	B	Saccharomyces boulardii - 200mg	200mg	Capsule	513,348 L.L
A07FA02	ULTRA LEVURE	B	Saccharomyces boulardii - 100mg	100mg	Powder for suspension	536,193 L.L
A07FA51	INFLORAN	B	Bifidobacterium infantis - 1milliard, Lactobacillus acidophilus - 1milliard		Capsule	647,732 L.L
A07XA04	HIDRASEC INFANTS	B	Racecadotril - 10mg	10mg	Granules for suspension	858,715 L.L
A07XA04	HIDRASEC	B	Racecadotril - 100mg	100mg	Capsule, hard	411,216 L.L
A07XA04	RACECADOTRIL ARROW	G	Racecadotril - 100mg	100mg	Capsule	583,228 L.L
A07XA04	RACECADOTRIL BGR	G	Racecadotril - 100mg	100mg	Capsule	575,165 L.L
A07XA04	RACECADOTRIL BIOGARAN CONSEIL	G	Racecadotril - 100mg	100mg	Capsule	287,582 L.L
A08AA01	LOMAIRA	B	Phentermine Hydrochloride - 8mg	8mg	Tablet	6,138,673 L.L
A08AA62	CONTRAVE	B	Naltrexone Hydrochloride - 8mg, Bupropion Hydrochloride - 90mg		Tablet, prolonged release	11,653,550 L.L
A08AB01	XENICAL	B	Orlistat - 120mg	120mg	Capsule	4,036,903 L.L
A08AB01	ELIZA 120	G	Orlistat - 120mg	120mg	Capsule	1,167,223 L.L
A08AB01	ELIZASLIM 120	G	Orlistat - 120mg	120mg	Capsule	1,167,223 L.L
A08AB01	LESSFAT	G	Orlistat - 120mg	120mg	Capsule	391,634 L.L

...

187